Trial intelligence / Profile preview

Travatan Z vs Xalatan Ocular Surface Health Study

NCT00690794Phase 3Completed

Sponsor
Alcon Inc.
Start
Jul 2008
Primary completion
May 2009
Modality
Prodrugs/Conditional Activator Small Molecules
01

Overview

A Phase 3 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Jul 2008; status: completed.

02

Drugs

travoprost
03

Conditions

open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on NCT00690794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00690794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call